DuPont De Nemours has been subject to significant interest from investment firms, with purchases of shares by Wells Fargo & Company MN, Aviva PLC, APG Asset Management N.V., Russell Investments Group Ltd, among others, signalling interest in the bio-tech firm. However, market fluctuations saw the company's shares slide by 26% last quarter, hitting new 1-Year lows. Some experts, like Jim Cramer, defend the company, suggesting they did nothing wrong despite ongoing investigations from Bronstein, Gewirtz & Grossman, LLC and others. Various financial adjustments have been made by companies like Invesco Ltd., Bank of Montreal, and Legal & General Group Plc. The company's dividend stocks are held in high esteem in spite of downgraded price targets by Wells Fargo, Citigroup, and JPMorgan Chase & Co. The company has initiated tech advances in the AI and water treatment sectors, hinting at their innovation capacity. Despite antitrust allegations from China, the firm's improved Q4 earnings, rising 2024 guidance, positive outlook for 2025, and strategic dividend hike have indicated a potential for growth in the face of volatility.
Dupont De Nemours DD News Analytics from Thu, 23 May 2024 07:00:00 GMT to Sat, 12 Apr 2025 23:42:30 GMT -
Rating 0
- Innovation 8
- Information 4
- Rumor -5
